Traders purchased shares of Johnson & Johnson (NYSE:JNJ) on weakness during trading on Friday. $123.59 million flowed into the stock on the tick-up and $89.85 million flowed out of the stock on the tick-down, for a money net flow of $33.74 million into the stock. Of all equities tracked, Johnson & Johnson had the 19th highest net in-flow for the day. Johnson & Johnson traded down ($0.26) for the day and closed at $119.08

Several research analysts have commented on the stock. BTIG Research restated a “hold” rating on shares of Johnson & Johnson in a research report on Sunday, May 22nd. Leerink Swann restated a “buy” rating on shares of Johnson & Johnson in a research report on Sunday, May 22nd. Morgan Stanley restated a “hold” rating on shares of Johnson & Johnson in a research report on Thursday, May 19th. Credit Suisse Group AG restated a “hold” rating and set a $112.00 price objective on shares of Johnson & Johnson in a research report on Thursday, May 19th. Finally, Wells Fargo & Co. restated a “buy” rating on shares of Johnson & Johnson in a research report on Wednesday, May 18th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and twelve have issued a buy rating to the company’s stock. Johnson & Johnson has a consensus rating of “Hold” and an average price target of $119.53.

The company has a market cap of $326.44 billion and a P/E ratio of 22.24. The stock has a 50-day moving average price of $122.43 and a 200-day moving average price of $114.84.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Tuesday, July 19th. The company reported $1.74 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.68 by $0.06. The company had revenue of $18.50 billion for the quarter, compared to analysts’ expectations of $17.98 billion. Equities analysts forecast that Johnson & Johnson will post $6.69 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, August 19th. Investors of record on Friday, August 5th were given a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 0.97%.

In related news, CAO Ronald A. Kapusta sold 2,935 shares of Johnson & Johnson stock in a transaction on Friday, July 22nd. The shares were sold at an average price of $125.01, for a total value of $366,904.35. Following the transaction, the chief accounting officer now owns 28,660 shares in the company, valued at approximately $3,582,786.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Ronald A. Kapusta sold 3,000 shares of Johnson & Johnson stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $115.79, for a total transaction of $347,370.00. Following the completion of the transaction, the chief accounting officer now owns 28,725 shares in the company, valued at approximately $3,326,067.75. The disclosure for this sale can be found here.

Other institutional investors have modified their holdings of the company. Private Capital Management Inc. acquired a new position in shares of Johnson & Johnson during the fourth quarter worth approximately $1,428,000. South Texas Money Management Ltd. boosted its position in shares of Johnson & Johnson by 9.4% in the fourth quarter. South Texas Money Management Ltd. now owns 17,265 shares of the company’s stock worth $1,773,000 after buying an additional 1,478 shares during the last quarter. West Chester Capital Advisors Inc. boosted its position in shares of Johnson & Johnson by 12.6% in the fourth quarter. West Chester Capital Advisors Inc. now owns 17,746 shares of the company’s stock worth $1,804,000 after buying an additional 1,984 shares during the last quarter. Wafra Investment Advisory Group Inc. NY boosted its position in shares of Johnson & Johnson by 10.0% in the fourth quarter. Wafra Investment Advisory Group Inc. NY now owns 22,608 shares of the company’s stock worth $2,322,000 after buying an additional 2,058 shares during the last quarter. Finally, Venturi Wealth Management LLC acquired a new position in shares of Johnson & Johnson during the fourth quarter worth approximately $2,920,000.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company’s segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.